1. MICS3 Data Analysis and Report Writing
Malaria
MICS3 Data Analysis and Report Writing

2. Background
An estimated million clinical malaria cases and more than one million malaria deaths occur each year, with 90% of these deaths in Sub-Saharan Africa.
Repeated episodes of fever and anemia take a toll on a child’s mental and physical development - impairing their education and their growth into productive adults.
Pregnant women and their unborn children are also particularly vulnerable to malaria, which is a major cause of low birth weight, anemia and infant death.

3. International Goals & Targets
Have halted and begun to reverse the incidence of malaria and other major diseases
Reduce by one half the burden of disease associated with malaria and ensure that 60% of all people at risk of malaria, especially children and women, sleep under insecticide-treated bednets

4. List of Indicators Household availability of ITNs or any net
Children under five sleeping under an ITN
Malaria treatment for children under five
Intermittent preventive malaria treatment

5. Definition of Indicators
Household Availability of ITNs or Any Net
Percentage of households with at least one
insecticide-treated net (or any net)
Numerator:
Number of households with at least one mosquito net,
either permanently treated or treated within the previous
12 months (or any net)
Denominator:
Number of households surveyed

6. Table CH.10: Availability of ITNs
Tabulation Plan
Table CH.10: Availability of ITNs

7. Definition of Indicators
Children Under-Five Sleeping Under ITNs
Percentage of children under five sleeping
under an insecticide-treated net
Numerator:
Number of children aged 0-59 months that slept under and
insecticide-treated net the previous night
Denominator:
Number of children aged 0-59 months surveyed

8. Definition of Indicators
Malaria Treatment in Children Under-Five
Percentage of children under five with reported
fever receiving antimalarials
Numerator:
Number of children aged 0-59 months reported to have
fever in the 2 weeks prior to the survey that were treated
with an appropriate antimalarial within 24 hours of onset
of symptoms
Denominator:
Number of children aged 0-59 months surveyed that were reported to have fever in the 2 weeks prior to the survey

9. Methodological Issues
Insecticide-treated nets include a mosquito net, either permanently treated or treated within the previous 12 months

10. Table CH.11: Children sleeping under bednets
Tabulation Plan
Table CH.11: Children sleeping under bednets

11. % children aged 0-59 months sleeping under an ITN
ITN Use
% children aged 0-59 months sleeping under an ITN

12. Methodological Issues
Appropriate antimalarial treatment includes SP/Fansidar, Chloroquine, Amodiaquine, Quinine, Artemisinin-based combinations or other antimalarials (not paracetamol, aspirin or ibuprofen) given same day or next day
Comparability issue since most surveys did not consider timing of anti-malarial treatment.
Growing resistance to Chloroquine and SP/Fansidar treatment in some areas, which reduces the effectiveness of those drugs.
Changes in drug policies for anti-malarial treatment.

13. Methodological Issues

14. Methodological Issues
Percentages given various antimalarials will not add to 100 since children may have been given more than one type of drug
Use of GPS (geocoding) to identify malarious parts of countries.

15. Methodological Issues
Issue of timing of antimalarial treatment:
any time v. same day/next day

16. Tabulation Plan (Antimalarials)

17. % children aged 0-59 months with fever receiving antimalarials
Antimalarial Use
% children aged 0-59 months with fever receiving antimalarials

18. Definition of Indicators
Intermittent Preventive Malaria Treatment
Percentage of pregnant women receiving
intermittent preventive malaria treatment (IPT)
Numerator:
Number of women receiving appropriate intermittent
medication to prevent malaria (defined as at least 2 doses
of SP/Fansidar) during the last pregnancy leading to a live
birth within the 2 years prior to the survey
Denominator:
Number of women who have had a live birth within the 2 years prior to the survey

19. Methodological Issues
Note that if the percentage of pregnant women receiving SP/Fansidar an unknown number of times is less than 1% this column may be omitted from the table

20. CH.13: Intermittent preventive treatment for malaria
Tabulation Plan
CH.13: Intermittent preventive treatment for malaria